Le Mans

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Chronic myeloid leukaemia1 trial
• Hidradenitis suppurativa1 trial
• Lung cancer1 trial
• Melanoma1 trial
• Myeloproliferative neoplasms1 trial

Phase

• Phase 32 trials

Status

• Active, not recruiting2 trials
• Completed2 trials
• Terminated1 trial

Lead sponsor

• Novartis Pharmaceuticals5 trials

Running trials

• Active, not recruiting

  Patient's Perspective on the Evolution of Hidradenitis Suppurativa Burden After Secukinumab Initiation

  NCT06444087· Novartis Pharmaceuticals· Source

• Active, not recruiting

  Asciminib Prospective Non Interventional Study as 3rd Line Therapy or More to Treat Adult Patients With CML- CP in Real World Setting in France

  NCT06092879· Novartis Pharmaceuticals· Source

Closed trials

• Completed

  A Study of Real-world Use and Effectiveness of Cytoreductive Strategies for the Treatment of Second-line Polycythemia Vera in France

  NCT07839858· Novartis Pharmaceuticals· Source

• Terminated

  A Study of the Anti-PD1 Antibody PDR001, in Combination With Dabrafenib and Trametinib in Advanced Melanoma

  NCT02967692· Phase 3· Novartis Pharmaceuticals· Source

• Completed

  LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib

  NCT01828112· Phase 3· Novartis Pharmaceuticals· Source